News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PsychoGenics Inc. Expands its In Vivo Capabilities with the Addition of Preclinical Magnetic Resonance Imaging Technology Services in Partnership with Ekam Imaging


2/8/2012 7:19:38 AM

TARRYTOWN, N.Y. & BOSTON--(BUSINESS WIRE)--PsychoGenics Inc. and Ekam Imaging, Inc., today announced the establishment of an alliance to provide Ekam’s specialized imaging services in awake animals to complement PsychoGenics’ testing capabilities and drug discovery services.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES